NCT02720263 A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT02717195 Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia Status COMPLETED Phase PHASE3
NCT02717130 Aripiprazole, Abilify Maintena Collaborative Clinical Protocol Status TERMINATED Phase NA
NCT02715765 The Use of Transcranial Electrical Stimulation for Hallucinations Status TERMINATED Phase NA
NCT02715349 Psychoeducation for Vietnamese Families With a Patient With Schizophrenia Status COMPLETED Phase NA
NCT02715128 Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex Status UNKNOWN Phase NA
NCT02714894 Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study Status UNKNOWN Phase N/A
NCT02713282 A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation Status COMPLETED Phase PHASE3
NCT02712463 A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics Status COMPLETED Phase N/A
NCT02709733 Virtual Rehabilitation for the Treatment of Motivational Deficits in Schizophrenia Status COMPLETED Phase NA
NCT02697045 Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch Status COMPLETED Phase PHASE4
NCT02694328 A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) Status COMPLETED Phase PHASE3
NCT02687984 PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia Status COMPLETED Phase PHASE1